Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
申请人:Bourrie Bernard
公开号:US20050222192A1
公开(公告)日:2005-10-06
The present invention relates to pyridoindolone derivatives substituted in the 3-position by a heterocyclic group of general formula (I):
in which:
R
1
represents a hydrogen atom or a (C
1
-C
4
)alkyl group;
R
2
represents a hydrogen atom or a (C
1
-C
4
)alkyl group;
R
3
represents a thienyl mono- or polysubstituted by a methyl group; or a monocyclic or bicyclic heterocyclic radical chosen from: a pyridyl, an N-oxidopyridinio, a pyrazolyl, an (N-phenyl)pyrazolyl, an (N-halophenyl)pyrazolyl, a furyl, an indolyl, an (N-benzyl)indolyl, an (N-halobenzyl)indolyl, a benzothienyl or a benzofuryl, the said radicals being unsubstituted or substituted one or more times by a halogen atom or a methyl or methoxy group;
R
4
and R
5
are identical or different and each independently represent a hydrogen or halogen atom or a hydroxyl, hydroxymethyl, (C
1
-C
4
)alkyl, trifluoromethyl, C
1
-C
4
)alkoxy, (C
1
-C
4
)alkoxycarbonyl or cyano group. Preparation process and application in therapeutics.
本发明涉及在3-位被一般式(I)的杂环基取代的吡啶吲哚酮衍生物,其中:R1代表氢原子或(C1-C4)烷基;R2代表氢原子或(C1-C4)烷基;R3代表被甲基单取代或多取代的噻吩基;或从中选择的单环或双环杂环基:吡啶基、N-氧代吡啉基、吡唑基、(N-苯基)吡唑基、(N-卤苯基)吡唑基、呋喃基、吲哚基、(N-苄基)吲哚基、(N-卤苄基)吲哚基、苯并噻吩基或苯并呋喃基,所述基未取代或经一次或多次取代,取代基为卤原子或甲基或甲氧基;R4和R5相同或不同,各自独立地代表氢或卤原子或羟基、羟甲基、(C1-C4)烷基、三氟甲基、(C1-C4)烷氧基、(C1-C4)烷氧羰基或氰基。制备方法和在治疗中的应用。